76 related articles for article (PubMed ID: 3798960)
1. Acetylator phenotype among individuals with glucose 6-phosphate dehydrogenase variants.
Jeyakumar LH; French MR
Xenobiotica; 1986 Dec; 16(12):1129-32. PubMed ID: 3798960
[TBL] [Abstract][Full Text] [Related]
2. Interactions of glucose-6-phosphate dehydrogenase deficiency with drug acetylation and hydroxylation reactions.
Magon AM; Leipzig RM; Zannoni VG; Brewer GJ
J Lab Clin Med; 1981 Jun; 97(6):764-70. PubMed ID: 7229511
[TBL] [Abstract][Full Text] [Related]
3. N-acetylation and oxidative capacity in aged volunteers determined with sulfamethazine and antipyrine.
Siegmund W; Franke G; Wulkow R; Hanke W; Thonack R
Int J Clin Pharmacol Ther Toxicol; 1991 Dec; 29(12):469-73. PubMed ID: 1813431
[TBL] [Abstract][Full Text] [Related]
4. Influence of acetylator phenotype of the leprosy patient on the emergence of dapsone resistant leprosy.
Raj PP; Aschhoff M; Lilly L; Balakrishnan S
Indian J Lepr; 1988 Jul; 60(3):400-6. PubMed ID: 3058828
[TBL] [Abstract][Full Text] [Related]
5. Hepatic acetylator phenotype in bladder cancer patients.
Ladero JM; Kwok CK; Jara C; Fernandez L; Silmi AM; Tapia D; Uson AC
Ann Clin Res; 1985; 17(3):96-9. PubMed ID: 4051447
[TBL] [Abstract][Full Text] [Related]
6. Polymorphic acetylation of sulphamethazine in a Zimbabwe population.
Nhachi CF
J Med Genet; 1988 Jan; 25(1):29-31. PubMed ID: 3351888
[TBL] [Abstract][Full Text] [Related]
7. Comparison between serum and urinary sulphadimidine acetylation as predictors of isoniazid acetylator status in patients with pulmonary tuberculosis.
Singh SP; Pande JN; Khilnani GC; Kailash S
Indian J Chest Dis Allied Sci; 1996; 38(1):5-11. PubMed ID: 16892742
[TBL] [Abstract][Full Text] [Related]
8. Isoniazid acetylating phenotype in patients with paracoccidioidomycosis and its relationship with serum sulfadoxin levels, glucose-6-phosphate dehydrogenase and glutathione reductase activities.
Barraviera B; Pereira PC; Machado JM; de Souza MJ; Lima CR; Curi PR; Mendes RP; Meira DA
Rev Soc Bras Med Trop; 1991; 24(2):111-4. PubMed ID: 1841426
[TBL] [Abstract][Full Text] [Related]
9. Dapsone-induced hemolytic anemia: role of glucose-6-phosphate dehydrogenase in the hemolytic response of rat erythrocytes to N-hydroxydapsone.
Grossman S; Budinsky R; Jollow D
J Pharmacol Exp Ther; 1995 May; 273(2):870-7. PubMed ID: 7752092
[TBL] [Abstract][Full Text] [Related]
10. Acetylator phenotyping with sulphadimidine in patients receiving isoniazid.
Ylitalo P; Auterinen L; Marttinen A; Koivula T
Int J Clin Pharmacol Res; 1984; 4(2):141-4. PubMed ID: 6469440
[TBL] [Abstract][Full Text] [Related]
11. [The potential clinical significance of the isoniazid acetylator phenotype in the treatment of pulmonary tuberculosis].
Ellard GA
Rev Mal Respir; 1984; 1(4):207-19. PubMed ID: 6505358
[TBL] [Abstract][Full Text] [Related]
12. Sulphamethoxazole acetylation in fast and slow acetylators.
Bozkurt A; Basci NE; Isimer A; Tuncer M; Erdal R; Kayaalp SO
Int J Clin Pharmacol Ther Toxicol; 1990 Apr; 28(4):164-6. PubMed ID: 2338369
[TBL] [Abstract][Full Text] [Related]
13. Association of microalbuminuria with slow acetylator phenotype in type 1 diabetes mellitus.
Madácsy L; Szórády I; Sánta A; Barkai L; Vámosi I
Child Nephrol Urol; 1992; 12(4):192-6. PubMed ID: 1473091
[TBL] [Abstract][Full Text] [Related]
14. Hepatic acetylator phenotype in diabetes mellitus.
Ladero JM; Arrojo A; de Salamanca RE; Gomez M; Cano F; Alfonso M
Ann Clin Res; 1982 Aug; 14(4):187-9. PubMed ID: 7168549
[TBL] [Abstract][Full Text] [Related]
15. [Changes in the activity of glucose-6-phosphate dehydrogenase and in the content of reduced glutathione in red blood corpuscles in the case of tumorous diseases in the maxillofacial region (author's transl)].
Warchoł T; Karoń H; Flieger S; Sarnowska I
Zahn Mund Kieferheilkd Zentralbl; 1978; 66(8):825-8. PubMed ID: 154265
[TBL] [Abstract][Full Text] [Related]
16. [Distribution of acetylator phenotypes in the Moscow population].
Lil'in ET; Korsunskaia MP; Meksin VA; Tarlycheva LV; Shapiro EF
Genetika; 1983 Aug; 19(8):1378-80. PubMed ID: 6685091
[TBL] [Abstract][Full Text] [Related]
17. Acetylation polymorphism and leprosy.
Eze LC; Okpogba AN; Ogan AU
Biochem Genet; 1990 Feb; 28(1-2):1-7. PubMed ID: 2344344
[TBL] [Abstract][Full Text] [Related]
18. Immunological evidence for N-acetyltransferase isozymes in the rabbit.
Reeves PT; Kinnear BF; Minchin RF; Ilett KF
Mol Pharmacol; 1991 Jan; 39(1):42-8. PubMed ID: 1987451
[TBL] [Abstract][Full Text] [Related]
19. [New variants of erythrocyte glucose-6-phosphate dehydrogenase].
Boivin P; Galand C
Rev Fr Etud Clin Biol; 1968 Jan; 13(1):30-9. PubMed ID: 5653554
[No Abstract] [Full Text] [Related]
20. Cloned mouse N-acetyltransferases: enzymatic properties of expressed Nat-1 and Nat-2 gene products.
Martell KJ; Levy GN; Weber WW
Mol Pharmacol; 1992 Aug; 42(2):265-72. PubMed ID: 1513324
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
